Mometason Apofri (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometason Apofri, is a corticosteroid presented as a nasal spray solution for nasal administration. It reduces inflammation in the nasal passages and is used to treat allergic rhinitis in adults and children. It is indicated for seasonal and perennial allergy symptoms, providing relief from nasal congestion, sneezing, and itching.

GNH USA supplies Mometason Apofri as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to EU GMP standards and providing the product to hospitals, pharmacies, and clinics worldwide through regulated distribution channels.

Mometasone furoate nasal spray is a corticosteroid that acts on inflammatory pathways in the nasal mucosa to control allergic rhinitis.

- Allergic rhinitis: reduces nasal inflammation, relieving congestion, sneezing, and itching. - Seasonal allergic rhinitis: provides symptom control during pollen seasons. - Perennial allergic rhinitis: maintains nasal patency and comfort year‑round. - Non‑allergic rhinitis: may improve nasal symptoms associated with irritant exposure. - Post‑operative nasal inflammation: can be used to reduce swelling after nasal surgery.

Mometasone furoate nasal spray may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation. - Epistaxis (nosebleeds). - Headache. - Throat irritation or dryness. - Cough. - Altered taste perception.

Serious or Rare Side Effects: - Nasal septal perforation. - Adrenal suppression with prolonged high‑dose use. - Severe allergic reaction (anaphylaxis). - Vision changes such as cataracts or glaucoma. - Persistent or worsening nasal bleeding.

When using Mometasone furoate nasal spray, consider the following precautions to ensure safe and effective therapy.

- Assess for nasal infection: avoid use if active infection is present. - Monitor for epistaxis: discontinue if persistent bleeding occurs. - Use lowest effective dose: limit exposure to reduce systemic effects. - Avoid concomitant nasal decongestant sprays: may increase irritation. - Pregnancy and lactation: consult a healthcare professional before use. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mometasone furoate nasal spray can interact with other medications; awareness of these interactions helps minimize risk.

Major Interactions (Avoid): - Systemic corticosteroids: may increase risk of adrenal suppression. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise systemic exposure.

Moderate Interactions (Monitor Closely): - Antifungal azoles: monitor for signs of systemic effects. - Ritonavir: may increase plasma levels. - Nasal antihistamines: may increase local irritation.